Pituitary Adenoma: Clinical Trials

6 trials for Pituitary Adenoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 completed, 1 enrolling by invitation. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Recruiting 3, Completed 2, Enrolling by invitation 1

Follow Pituitary Adenoma: new trials by email Literature Review of Pituitary Adenoma trials Research Report on Pituitary Adenoma

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors
Hormone replacement therapy, Placebo - Pituitary Adenoma, Pituitary Neuroendocrine Tumor
Phase 4RecruitingBeijing Tiantan Hospital8822024-12-042025-01-14
Cabergoline in the Management of Nonfunctioning Pituitary Adenoma
Cabergoline 0.5 MG - Pituitary Adenoma, MRI
Phase 4Enrolling by invitationNational Taiwan University Hospital302024-05-202025-06-24
Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery
sevoflurane, propofol - Pituitary Adenoma
Phase 4CompletedPeking Union Medical College Hospital2522023-05-032025-06-08
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
Ga68-DOTATATE-PET/MRI - CNS Tumors, Meningioma
Phase 4RecruitingWeill Medical College of Cornell University2002019-09-042026-10-30
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
Placebo, Oral Antibiotics cefdinir or trimethoprim/sulfamethoxazole - Antibiotics, Pituitary Adenoma
Phase 4RecruitingSt. Joseph's Hospital and Medical Center, Phoenix1162017-07-012018-08-15
Surgical Debulking of Pituitary Adenomas
Octreotide LAR, transsphenoidal surgery - Pituitary Adenoma
Phase 4CompletedNYU Langone Health412004-04-012016-08-29

Narrower conditions

Pituitary Neoplasms (6)  ·  Central Nervous System Neoplasms (1)  ·  Esthesioneuroblastoma, Olfactory (1)  ·  Hemangioblastoma (1)  ·  Medulloblastoma (1)  ·  Meningioma (1)  ·  Paraganglioma (1)

Broader conditions

Brain Diseases (6)  ·  Brain Neoplasms (6)  ·  Central Nervous System Diseases (6)  ·  Endocrine Gland Neoplasms (6)  ·  Endocrine System Diseases (6)  ·  Hypothalamic Diseases (6)  ·  Hypothalamic Neoplasms (6)  ·  Neoplasms (6)  ·  Neoplasms by Site (6)  ·  Nervous System Diseases (6)  ·  Nervous System Neoplasms (6)  ·  Pituitary Diseases (6)  ·  Supratentorial Neoplasms (6)  ·  Central Nervous System Neoplasms (5)  ·  Cranial Nerve Diseases (1)

Interventions

Cabergoline (1)  ·  Cefdinir (1)  ·  Hormone Replacement Therapy (1)  ·  Propofol (1)  ·  Sevoflurane (1)  ·  Sulfamethoxazole (1)  ·  Trimethoprim (1)

Sponsors

Beijing Tiantan Hospital (1)  ·  NYU Langone Health (1)  ·  National Taiwan University Hospital (1)  ·  Peking Union Medical College Hospital (1)  ·  St. Joseph's Hospital and Medical Center, Phoenix (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (3)  ·  China (2)  ·  Taiwan (1)

Top investigators

Andrew Little, MD (1)  ·  Bing Xing, MD (1)  ·  David M Kleinberg, MD (1)  ·  James Evans, MD (1)  ·  Jana Ivanidze, MD/Ph.D (1)  ·  Lulu Ma, MD (1)  ·  Wei Lian, MD (1)  ·  Yuguang Huang, MD (1)

Results publications

PMID 35275019, PMID 35661809, PMID 38553990, PMID 40760415